Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medibank PvtASX:MPL -0.59%79 EV-to-EBITDA is 17.32 as of Jul. 14, 2026, which is 35% above its 10-year median of 12.80. GuruFocus rates ASX:MPL with a GF Score™ of 79/100 and a GF Value™ of A$4.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 348 Insurance companies, Medibank Pvt ranks worse than 85.63% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medibank Pvt's enterprise value is A$13,730 Mil.
Medibank Pvt's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$793 Mil. Therefore, Medibank Pvt's EV-to-EBITDA for today is 17.32.
The historical rank and industry rank for Medibank Pvt's EV-to-EBITDA or its related term are showing as below:
ASX:MPL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.39 Med: 12.8 Max: 17.42
Current: 17.32
During the past 11 years, the highest EV-to-EBITDA of Medibank Pvt was 17.42. The lowest was 10.39. And the median was 12.80.
ASX:MPL's EV-to-EBITDA is ranked worse than 85.63% of 348
companies
in the Insurance industry
Industry Median: 8.405
vs ASX:MPL: 17.32
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Medibank Pvt (ASX:MPL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medibank Pvt's PE Ratio (TTM) for today is calculated as:
Medibank Pvt's share price for today is A$5.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medibank Pvt's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.168.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medibank Pvt's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Specialty subindustry, Medibank Pvt's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt EV-to-EBITDA vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's EV-to-EBITDA falls into.
Medibank Pvt's current Enterprise Value is A$13,730 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medibank Pvt's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$793 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a EV-to-EBITDA of 17.32 as of Jul. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medibank Pvt. This is 35% above median its historical median of 12.80. Over the past decade, Medibank Pvt's EV-to-EBITDA has ranged from 10.39 to 17.42. According to the industry distribution chart, Medibank Pvt ranks #298 out of 348 companies in the Insurance industry, placing it in the top 85.6%.
Is Medibank Pvt's EV-to-EBITDA too high?
Medibank Pvt's current EV-to-EBITDA of 17.32 is 35% above median its 10-year median of 12.80. Over the past 10 years, this metric has ranged from a low of 10.39 to a high of 17.42. The Insurance industry median EV-to-EBITDA is 8.41. Medibank Pvt's value of 17.32 is 106.1% above this industry median. Based on the distribution chart, Medibank Pvt ranks #298 out of 348 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Medibank Pvt has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's EV-to-EBITDA compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #298 out of 348 companies for EV-to-EBITDA. This places Medibank Pvt in the lower half of its industry. The industry median EV-to-EBITDA is 8.41. Medibank Pvt's value of 17.32 is 106.1% above this benchmark. Historically, Medibank Pvt's own EV-to-EBITDA has ranged from 10.39 to 17.42 over the past decade. While the company's 10-year median is 12.80 vs. the industry median of 8.41, Medibank Pvt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Insurance company?
The median EV-to-EBITDA among Insurance companies is 8.41, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current EV-to-EBITDA of 17.32 is 106.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medibank Pvt. For the Insurance industry, the median EV-to-EBITDA is 8.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current EV-to-EBITDA is 17.32, which is 35% above median its own 10-year median of 12.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.40, compared to a current price of A$5.05 — trading 14.8% above its estimated fair value. The current EV-to-EBITDA is 17.32, which is 35% above median its 10-year median of 12.80 and 106.1% above the Insurance industry median of 8.41. Medibank Pvt's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current EV-to-EBITDA is 17.32 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.05 is trading 14.8% above its estimated GF Value™ of A$4.40.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
EV-to-EBITDA: 17.32 (35% above median its 10-year median of 12.80)
GF Value™: A$4.40 vs. price of A$5.05 (14.8% above fair value)
Industry Position: 106.1% above the Insurance median (#298 of 348)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
79GF Score
Get the complete analysis for ASX:MPL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
